From Wikipedia, the free encyclopedia
 |
Rivastigmine is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome. |
| B |
This article has been rated as B-Class on the quality scale. |
| High |
This article has been rated as high-importance for this Project's importance scale. |
|
The paragraph about the patch is a bit of a stretch--can we remove it? I have seen stuff that says the side effect profile is down. They presented at ICAD 2006 in Madrid. --Chrispounds 01:37, 6 January 2007 (UTC)